This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

CorMatrix ECM for Carotid Repair Following Endarterectomy Registry

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Aziyo Biologics, Inc.
ClinicalTrials.gov Identifier:
NCT01569594
First received: March 30, 2012
Last updated: June 28, 2017
Last verified: June 2017
  Purpose
The objective of this registry is to capture and assess device performance data from subjects undergoing patch angioplasty of the carotid artery following carotid endarterectomy using the CorMatrix ECM for Carotid Repair per its FDA cleared Indications for Use. This registry provides an ongoing post-market surveillance mechanism to document clinical outcomes on the use of the CorMatrix ECM for Carotid Repair.

Condition Intervention
Carotid Stenosis Device: CorMatrix ECM for Carotid Repair

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: CorMatrix® ECM® for Carotid Repair Following Endarterectomy Registry

Further study details as provided by Aziyo Biologics, Inc.:

Primary Outcome Measures:
  • Carotid procedure and device related adverse events to determine device performance [ Time Frame: 2 years ]
    Carotid procedure and device related adverse events to determine device performance


Enrollment: 230
Study Start Date: April 2012
Study Completion Date: December 31, 2016
Primary Completion Date: December 31, 2016 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Carotid Endarterectomy Subjects Device: CorMatrix ECM for Carotid Repair
Subjects must be undergoing carotid endarterectomy with patch angioplasty closure

  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Up to 230 subjects may be enrolled from up to ten U.S. clinical sites
Criteria

Inclusion Criteria:

  • Subjects must be undergoing carotid endarterectomy with patch angioplasty closure.
  • Subject's operative surgeon intends to use CorMatrix ECM as the patch material for closure of the carotid artery per its FDA cleared Indications for Use.
  • The subject must possess the ability to provide written Informed Consent.
  • The subject must express an understanding and willingness to fulfill all of the expected requirements of this clinical protocol.

Exclusion Criteria:

  • Subjects with a known sensitivity to porcine material.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01569594

Locations
United States, Alabama
Cardio-Thoracic Surgeons, P.C. Trinity
Birmingham, Alabama, United States, 35243
United States, Georgia
Vascular Surgical Associates P.C.
Marietta, Georgia, United States, 30060
United States, Indiana
Cardiac Surgery Associates
Indianapolis, Indiana, United States, 46237
United States, Missouri
St Luke's Hospital
Kansas City, Missouri, United States, 64111
United States, Tennessee
Cardiovascular Surgery Clinic, PLLC
Memphis, Tennessee, United States, 38120
United States, Virginia
UVA Heart and Vascular Center
Charlottesville, Virginia, United States, 22908
Sponsors and Collaborators
Aziyo Biologics, Inc.
Investigators
Study Director: Andrew Green Chief Business Officer
  More Information

Responsible Party: Aziyo Biologics, Inc.
ClinicalTrials.gov Identifier: NCT01569594     History of Changes
Other Study ID Numbers: 11-PR-1021
Study First Received: March 30, 2012
Last Updated: June 28, 2017

Additional relevant MeSH terms:
Carotid Stenosis
Carotid Artery Diseases
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on August 18, 2017